Clinical Trial Update: A Single-patient Clinical Trial of MAS825 in a Patient With XIAP Deficiency [Phase 3]

View source ↗

Summary

A single-patient Phase 3 trial of MAS825 for XIAP deficiency (XLP-2) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Lymphoproliferative Syndrome Type 2

Drugs mentioned

• MAS825

Snippet

Sponsor: The Hospital for Sick Children | Conditions: X-linked Lymphoproliferative Syndrome Type 2 (XLP-2) | Phase 3 | Status: COMPLETED